InnSuites Hospitality Trust (IHT)
InnSuites Hospitality Trust (IHT) is a real estate investment trust that owns and operates hotels primarily in the southwestern United States. Established to provide investors with income from the hospitality sector, IHT focuses on acquiring and managing full-service hotels to generate rental income and capital appreciation. The company's portfolio includes properties that are leased or managed, emphasizing midscale to upscale accommodations.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| August 7, 2025 | $0.01 | 2025-07-25 | 2025-07-25 |
| February 5, 2025 | $0.01 | 2025-01-24 | 2025-01-24 |
| July 31, 2024 | $0.01 | 2024-07-19 | 2024-07-19 |
| February 5, 2024 | $0.01 | 2024-01-19 | 2024-01-22 |
| July 31, 2023 | $0.01 | 2023-07-19 | 2023-07-20 |
Dividends Summary
- InnSuites Hospitality Trust has issued 29 dividend payments over the past 19 years
- The most recent dividend was paid 44 days ago, on August 7, 2025
- The highest dividend payed out to investors during this period was $0.01 per share
- The average dividend paid during this period was $0.01 per share.
Company News
InnSuites Hospitality Trust reported over $4 million in hotel revenue for the first half of fiscal year 2026, continued its 55-year dividend streak, and expanded into independent hotel reservations and clean energy investments.
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share. Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 169% to $9.90 after the company announced that it entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases. Cingulate Inc. (NASDAQ: CING) gained 95.2% to $4.08. RiskOn International, Inc. (NASDAQ: ROI) shares climbed 91.8% to $0.27. RiskOn International expects to announce its new generative AI platform and technology partner on Jan. 3, 2024. Cytokinetics, Incorporated (NASDAQ: CYTK) surged 64.2% to $75.05 after the company announced topline results from SEQUOIA-HCM, the Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy. AEye, Inc. (NASDAQ: LIDR) rose 61.2% to $3.58. Vince Holding Corp. (NYSE: VNCE) jumped 42% to $3.2399. Bit Brother Limited(NASDAQ: BETS) gained 38.2% to $0.0152 after jumping 111% on Tuesday. Nxu, Inc. (NASDAQ: NXU) rose 34% to $4.18. Virax Biolabs Group Limited (NASDAQ: VRAX) gained 32% to $1.7551. Jet.AI Inc. (NASDAQ: JTAI) shares gained 28% to $2.05 after falling 39% on Tuesday. Elicio Therapeutics, Inc. (NASDAQ: ELTX) jumped 25% to $8.89. Elicio Therapeutics 10% owner GKCC, LLC acquired a total of 1,213,000 shares an average price of $5.81. Matinas BioPharma Holdings, Inc. (NASDAQ: MTNB) gained 24.7% to ...